H HaganSummaryAffiliation: New York University Country: USA Publications
| Collaborators
|
Detail Information
Publications
Sexual and injection-related risks in Puerto Rican-born injection drug users living in New York City: A mixed-methods analysisCamila Gelpi-Acosta
National Development and Research Institutes, Inc, New York, NY, USA
Harm Reduct J 8:28. 2011..abstract:..
Attribution of hepatitis C virus seroconversion risk in young injection drug users in 5 US citiesHolly Hagan
College of Nursing, New York University, USA
J Infect Dis 201:378-85. 2010..Avoiding HCV infection will require substantial reductions in exposure to all sources of contaminated blood...- Herpes simplex virus type 2 associated with HIV infection among New York heterosexuals living in high-risk areasH Hagan
New York University College of Nursing, New York, NY 10003, USA
Int J STD AIDS 21:580-3. 2010.... - Sexual risk and HIV infection among drug users in New York City: a pilot studyHolly Hagan
College of Nursing, New York University, New York, New York 10003, USA
Subst Use Misuse 46:201-7. 2011..The study's limitations are noted... - A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugsHolly Hagan
New York University College of Nursing, NY, USA
J Infect Dis 204:74-83. 2011..The objective of this paper was to meta-analyze the effects of risk-reduction interventions on HCV seroconversion and identify the most effective intervention types... - Current and emerging research needs in studying the NYC HIV-drug use epidemicSherry Deren
Center for Drug Use and HIV Research, College of Nursing, New York University, New York, New York, USA
Subst Use Misuse 46:316-9. 2011..While this summary does not represent a comprehensive list, it is based on many of the questions raised in the articles in this Special Issue and identifies some of the directions to be investigated during the next decade... 
Hepatitis C virus infection among injection drug users: survival analysis of time to seroconversionHolly Hagan
Center for Drug Use and HIV Research, National Development and Research Institutes, New York, New York 10010, USA
Epidemiology 15:543-9. 2004....- Meta-regression of hepatitis C virus infection in relation to time since onset of illicit drug injection: the influence of time and placeHolly Hagan
Center for Drug Use and HIV Research, National Development and Research Institutes NDRI, 71 West 23rd Street, New York, NY 10010, USA
Am J Epidemiol 168:1099-109. 2008..More rapid onset of HCV infection in drug injectors in developing/transitional countries resembles an earlier era of the HCV epidemic in other regions... - The HCV Synthesis Project: scope, methodology, and preliminary resultsRebecca K Stern
Center for Drug Use and HIV Research, National Development and Research Institutes NDRI, 71 West 23rd Street, 8th Floor, New York, NY 10010, USA
BMC Med Res Methodol 8:62. 2008..The hepatitis C virus (HCV) is hyper-endemic in injecting drug users. There is also excess HCV among non-injection drug users who smoke, snort, or sniff heroin, cocaine, crack, or methamphetamine... - Positive deviance control-case life history: a method to develop grounded hypotheses about successful long-term avoidance of infectionSamuel R Friedman
National Development and Research Institutes, Inc, 71 West 23d Street, 8th Floor, New York, NY 10010, USA
BMC Public Health 8:94. 2008..Prevalence rates for long-term injection drug users in some localities surpass 60% for HIV and 80% for HCV. We describe methods for developing grounded hypotheses about how some injectors avoid infection with either virus... - Drug treatment program patients' hepatitis C virus (HCV) education needs and their use of available HCV education servicesShiela M Strauss
National Development and Research Institutes, Inc, New York, NY 10010, USA
BMC Health Serv Res 7:39. 2007..Little is known, however, about the level of HCV knowledge among drug treatment program patients, and the extent to which they utilize their programs' HCV education services... - Design and feasibility of a randomized behavioral intervention to reduce distributive injection risk and improve health-care access among hepatitis C virus positive injection drug users: the Study to Reduce Intravenous Exposures (STRIVE)Farzana Kapadia
Guttmacher Institute, New York, NY 10005, USA
J Urban Health 84:99-115. 2007.... - Case-reporting of acute hepatitis B and C among injection drug usersHolly Hagan
National Development and Research Institutes, New York, New York, USA
J Urban Health 79:579-85. 2002..7%, and for hepatitis B, it was 7.5%. In this study, reporting of acute hepatitis in IDUs was extremely low, raising questions regarding the use of community surveillance data to estimate underlying incidence in that population group... - Eligibility for treatment of hepatitis C virus infection among young injection drug users in 3 US citiesHolly Hagan
National Development and Research Institutes, Center for Drug Use and HIV Research, New York, NY, 10010, USA
Clin Infect Dis 42:669-72. 2006..g., problem drinking, moderate-to-severe depression, and recent drug injection). Restrictive eligibility criteria may deny treatment to a large proportion of patients who could benefit from it... - Using latent class analysis to identify patterns of hepatitis C service provision in drug-free treatment programs in the U.SShiela M Strauss
National Development and Research Institutes, Inc, 71 West 23rd Street, 8th Floor, New York, NY 10010, USA
Drug Alcohol Depend 83:15-24. 2006..Similar analyses in other countries can inform their policy makers about the capacity of their drug treatment programs to provide support to their HCV infected patients... - Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990-2001Don C Des Jarlais
Beth Israel Medical Center, New York, NY 10038, USA
AIDS 19:S20-5. 2005..The 1990-2001 time period included a very large expansion of syringe exchange in New York City, from 250,000 to 3,000,000 syringes exchanged annually... - The content and comprehensiveness of hepatitis C education in methadone maintenance and drug-free treatment unitsShiela M Strauss
National Development and Research Institutes Inc, 71 West 23rd Street, 8th Floor, New York, NY 10010, USA
J Urban Health 81:38-47. 2004..Drug treatment programs need to educate patients about the proactive steps these individuals can take to deal with HCV, provide critically needed HCV services, and encourage patients to make full use of these services... - HIV/hepatitis C virus co-infection in drug users: risk behavior and preventionHolly Hagan
Center for Drug Use and HIV Research, National Development and Research Institute, New York, NY 10010, USA
AIDS 19:S199-207. 2005.... - Outpatient drug treatment program directors' hepatitis C-related beliefs and their relationship to the provision of HCV servicesJanetta M Astone
National Development and Research Institutes, Inc, 71 West 23rd St, 8th Floor, New York, NY 10010, USA
Am J Drug Alcohol Abuse 30:783-97. 2004..Our findings indicate that there is a positive significant relationship between director's beliefs and the provision of HCV antibody testing, follow-up testing, and the provision of HCV medication... - Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York CityDon C Des Jarlais
Beth Israel Medical Center, New York, New York 10038, USA
AIDS 21:231-5. 2007..As HIV is efficiently transmitted through the sharing of drug-injecting equipment, HIV infection has historically been higher among injecting drug users... - "Informed altruism" and "partner restriction" in the reduction of HIV infection in injecting drug users entering detoxification treatment in New York City, 1990-2001Don C Des Jarlais
Beth Israel Medical Center and dagger National Development and Research Institutes, Inc, New York, NY, USA
J Acquir Immune Defic Syndr 35:158-66. 2004..To assess recent developments in the HIV epidemic in injecting drug users (IDUs) in New York City. With >50,000 cases of AIDS in IDUs, New York has experienced the largest HIV/AIDS epidemic in IDUs of any city in the world... - A comparison of HCV antibody testing in drug-free and methadone maintenance treatment programs in the United StatesShiela M Strauss
National Development and Research Institutes, Inc, 71 West 23rd Street, 8th Floor, New York, NY 10010, USA
Drug Alcohol Depend 73:227-36. 2004.... - Heterosexual HIV and sexual partnerships between injection drug users and noninjection drug usersSamuel M Jenness
HIV Epidemiology Program, New York City Department of Health and Mental Hygiene, New York, New York 10013, USA
AIDS Patient Care STDS 24:175-81. 2010..Prevention interventions to encourage the disclosure of injection history and risk reduction specifically for those with IDU partners are indicated... - Integrating hepatitis C services into existing HIV services: the experiences of a sample of U.S. drug treatment unitsShiela M Strauss
National Development and Research Institutes, Inc, New York, New York 10010, USA
AIDS Patient Care STDS 19:78-88. 2005..Policy makers and individual treatment units need to develop strategies that capitalize on existing infrastructures while maintaining the distinction between HIV and HCV primary and secondary prevention efforts... - Medical examinations at entry to treatment for drug abuse as an opportunity to initiate care for hepatitis C virus infectionHolly Hagan
Center for Drug Use and HIV Research, National Development and Research Institutes, New York, New York 10010, USA
Clin Infect Dis 40:S297-303. 2005..05). With high dropout rates in the early stages of treatment for drug addiction, these medical visits may be an important opportunity for further monitoring and care for HCV infection and other conditions... - The transition from injection to non-injection drug use: long-term outcomes among heroin and cocaine users in New York CityDon C Des Jarlais
Beth Israel Medical Center, Baron Edmond de Rothschild Chemical Dependency Institute, New York, NY 10038, USA
Addiction 102:778-85. 2007..To characterize heroin and cocaine users in New York City who have changed from injection to non-injection drug administration and to identify factors associated with long-term non-injection use... - Residential substance user treatment programs as venues for HCV pharmacological treatment: client and staff perspectivesShiela M Strauss
National Development and Research Institutes, Inc, 71 West 23rd Street, 8th Floor, New York, New York 10010, USA
Subst Use Misuse 40:1811-29. 2005..Findings illuminate the complex issues involved for both clients and the programs, and some steps that programs can take to better support HCV-infected clients regarding HCV medication concerns... - Persistence and change in disparities in HIV infection among injection drug users in New York City after large-scale syringe exchange programsDon C Des Jarlais
Beth Israel Medical Center, 160 Water St 24th Fl, New York, NY 10038, USA
Am J Public Health 99:S445-51. 2009..We examined racial/ethnic disparities in HIV infection among injection drug users (IDUs) before and after implementation of large-scale syringe exchange programs in New York City... - Correlates of drug treatment program staff's self efficacy to support their clients' hepatitis C virus (HCV) related needsShiela M Strauss
National Development and Research Institutes, Inc, New York, New York 10010, USA
Am J Drug Alcohol Abuse 33:245-51. 2007..Efforts should focus on increasing staff's HCV knowledge in order to increase their confidence in providing HCV related support to their clients... - Staff perspectives on facilitating the implementation of hepatitis C services at drug treatment programsCorrine E Munoz-Plaza
STOP HEP C Project, New York, NY, USA
J Psychoactive Drugs 38:233-41. 2006..While programs need more funding and resources to overcome these barriers, these findings may prove helpful to other drug treatment programs that would like to offer HCV services to at least some of their clients... - Gaps in the drug-free and methadone treatment program response to Hepatitis CShiela M Strauss
National Development and Research Institutes, Inc, 71 West 23 Street, 8th Floor, 10010, New York, NY, USA
J Subst Abuse Treat 24:291-7. 2003..Managers of drug-free programs would like to be offering patients more HCV education, while MMTP managers would like to be providing more HCV testing to their patients, and more support and care for patients who are HCV+... - Hepatitis C knowledge among staff in U.S. drug treatment programsShiela M Strauss
National Developmental and Research Institutes, Inc, New York, NY 10010, USA
J Drug Educ 36:141-58. 2006..The majority of those in the latter group had never participated in a training specifically devoted to HCV. Results suggest the need for effective HCV-related training for all staff in drug treatment programs...